首页 > 最新文献

European heart journal. Digital health最新文献

英文 中文
Corrigendum to: ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients : In collaboration with the Council on Stroke, the European Heart Rhythm Association, and the Digital Health Committee. ESC电子心脏病学立场文件工作组的勘误表:心电图监测在隐源性卒中患者房颤检测中的准确性和可靠性:与卒中理事会、欧洲心律协会和数字健康委员会合作。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztad019

[This corrects the article DOI: 10.1093/ehjdh/ztac026.].

[这更正了文章DOI: 10.1093/ehjdh/ztac026.]。
{"title":"Corrigendum to: ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients : In collaboration with the Council on Stroke, the European Heart Rhythm Association, and the Digital Health Committee.","authors":"","doi":"10.1093/ehjdh/ztad019","DOIUrl":"https://doi.org/10.1093/ehjdh/ztad019","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/ehjdh/ztac026.].</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"138"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d1/71/ztad019.PMC10039420.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9547118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PubMed indexation for the European Heart Journal - Digital Health: a small step for the European Heart Journal family, a giant leap in the digital future of cardiovascular disease management. PubMed索引欧洲心脏杂志-数字健康:欧洲心脏杂志家族的一小步,心血管疾病管理的数字化未来的巨大飞跃。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztad013
Peter de Jaegere, Robert van der Boon, Joost Lumens, Nico Bruining
{"title":"PubMed indexation for the European Heart Journal - Digital Health: a small step for the European Heart Journal family, a giant leap in the digital future of cardiovascular disease management.","authors":"Peter de Jaegere,&nbsp;Robert van der Boon,&nbsp;Joost Lumens,&nbsp;Nico Bruining","doi":"10.1093/ehjdh/ztad013","DOIUrl":"https://doi.org/10.1093/ehjdh/ztad013","url":null,"abstract":"","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"63-64"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039422/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewers and awards. 评审员和奖项。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztad003
Nico Bruining, Peter de Jaegere, Joost Lumens
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal – Digital Health or of the European Society of Cardiology. * Corresponding author. Tel: +31 651733542, Email: n.bruining@erasmusmc.nl © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The peer-review process of the European Heart Journal – Digital Health (EHJ-DH) would not have been possible without the voluntary efforts of our reviewers, who kindly devoted their precious time to this crucial part of science. The editors realize very well that it is not always easy, often even very difficult, to find the time for this. We would like to thank you all very much for that! For us as editors, but certainly also for the authors, your reviews have been of great value. It has aided our decision-making, and it was very helpful to many authors to improve their submissions through your comments and pointers. It improved the scientific quality of many manuscripts and thus the journal considerably. Thanks in part to this effort, we received indexation in the Directory of Open Access Journals early last year already. This will help further growth and expansion of the journal besides the realization of our ambitions, which is among others to become the leading journal in cardiovascular Digital Health. In the past year, 229 reviewers helped us in the evaluation of the manuscripts we received. A special thanks go to our 10 top reviewers, albeit 13 this year, with the top ranking by this year for Dr Robert van der Boon, who is now one of our deputy editors (Figure 1). Below in alphabetical order the names of all our reviewers for the European Heart Journal – Digital Health over the past year. In case we would have forgotten someone by an unfortunate mistake, please accept our apology for this unintentional omission! The Editorial team.
{"title":"Reviewers and awards.","authors":"Nico Bruining,&nbsp;Peter de Jaegere,&nbsp;Joost Lumens","doi":"10.1093/ehjdh/ztad003","DOIUrl":"https://doi.org/10.1093/ehjdh/ztad003","url":null,"abstract":"The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal – Digital Health or of the European Society of Cardiology. * Corresponding author. Tel: +31 651733542, Email: n.bruining@erasmusmc.nl © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The peer-review process of the European Heart Journal – Digital Health (EHJ-DH) would not have been possible without the voluntary efforts of our reviewers, who kindly devoted their precious time to this crucial part of science. The editors realize very well that it is not always easy, often even very difficult, to find the time for this. We would like to thank you all very much for that! For us as editors, but certainly also for the authors, your reviews have been of great value. It has aided our decision-making, and it was very helpful to many authors to improve their submissions through your comments and pointers. It improved the scientific quality of many manuscripts and thus the journal considerably. Thanks in part to this effort, we received indexation in the Directory of Open Access Journals early last year already. This will help further growth and expansion of the journal besides the realization of our ambitions, which is among others to become the leading journal in cardiovascular Digital Health. In the past year, 229 reviewers helped us in the evaluation of the manuscripts we received. A special thanks go to our 10 top reviewers, albeit 13 this year, with the top ranking by this year for Dr Robert van der Boon, who is now one of our deputy editors (Figure 1). Below in alphabetical order the names of all our reviewers for the European Heart Journal – Digital Health over the past year. In case we would have forgotten someone by an unfortunate mistake, please accept our apology for this unintentional omission! The Editorial team.","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"65-68"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/52/ztad003.PMC10039425.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9547117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of a novel numerical model to predict regionalized blood flow in the coronary arteries. 一种预测冠状动脉血流区域化的新型数值模型的验证。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztac077
Daniel J Taylor, Jeroen Feher, Krzysztof Czechowicz, Ian Halliday, D R Hose, Rebecca Gosling, Louise Aubiniere-Robb, Marcel Van't Veer, Danielle C J Keulards, Pim Tonino, Michel Rochette, Julian P Gunn, Paul D Morris

Aims: Ischaemic heart disease results from insufficient coronary blood flow. Direct measurement of absolute flow (mL/min) is feasible, but has not entered routine clinical practice in most catheterization laboratories. Interventional cardiologists, therefore, rely on surrogate markers of flow. Recently, we described a computational fluid dynamics (CFD) method for predicting flow that differentiates inlet, side branch, and outlet flows during angiography. In the current study, we evaluate a new method that regionalizes flow along the length of the artery.

Methods and results: Three-dimensional coronary anatomy was reconstructed from angiograms from 20 patients with chronic coronary syndrome. All flows were computed using CFD by applying the pressure gradient to the reconstructed geometry. Side branch flow was modelled as a porous wall boundary. Side branch flow magnitude was based on morphometric scaling laws with two models: a homogeneous model with flow loss along the entire arterial length; and a regionalized model with flow proportional to local taper. Flow results were validated against invasive measurements of flow by continuous infusion thermodilution (Coroventis™, Abbott). Both methods quantified flow relative to the invasive measures: homogeneous (r 0.47, P 0.006; zero bias; 95% CI -168 to +168 mL/min); regionalized method (r 0.43, P 0.013; zero bias; 95% CI -175 to +175 mL/min).

Conclusion: During angiography and pressure wire assessment, coronary flow can now be regionalized and differentiated at the inlet, outlet, and side branches. The effect of epicardial disease on agreement suggests the model may be best targeted at cases with a stenosis close to side branches.

目的:缺血性心脏病是由冠状动脉血流不足引起的。直接测量绝对流量(mL/min)是可行的,但在大多数导管实验室尚未进入常规临床实践。因此,介入心脏病专家依赖于血流的替代标记物。最近,我们描述了一种计算流体动力学(CFD)方法,用于在血管造影期间区分入口、侧分支和出口流动。在目前的研究中,我们评估了一种新的方法,沿着动脉的长度来划分血流。方法与结果:对20例慢性冠状动脉综合征患者的血管造影资料进行冠状动脉三维解剖重建。通过将压力梯度应用于重建的几何形状,使用CFD计算所有流动。侧枝流动模拟为多孔壁面边界。侧支流量大小基于形态学标度规律,有两种模型:沿整个动脉长度的流量损失均匀模型;建立了流量与局部锥度成正比的区域化模型。通过连续输注热稀释(Coroventis™,雅培)进行有创性流量测量,验证流量结果。两种方法都量化了相对于侵入性措施的流量:均质性(r 0.47, P 0.006;零偏差;95% CI -168 ~ +168 mL/min);区域化方法(r 0.43, P 0.013;零偏差;95% CI -175 ~ +175 mL/min)。结论:在血管造影和压力线评估中,冠状动脉血流可以在入口、出口和侧支进行分区和区分。心外膜疾病对一致性的影响表明该模型可能最适合侧支狭窄的病例。
{"title":"Validation of a novel numerical model to predict regionalized blood flow in the coronary arteries.","authors":"Daniel J Taylor,&nbsp;Jeroen Feher,&nbsp;Krzysztof Czechowicz,&nbsp;Ian Halliday,&nbsp;D R Hose,&nbsp;Rebecca Gosling,&nbsp;Louise Aubiniere-Robb,&nbsp;Marcel Van't Veer,&nbsp;Danielle C J Keulards,&nbsp;Pim Tonino,&nbsp;Michel Rochette,&nbsp;Julian P Gunn,&nbsp;Paul D Morris","doi":"10.1093/ehjdh/ztac077","DOIUrl":"https://doi.org/10.1093/ehjdh/ztac077","url":null,"abstract":"<p><strong>Aims: </strong>Ischaemic heart disease results from insufficient coronary blood flow. Direct measurement of absolute flow (mL/min) is feasible, but has not entered routine clinical practice in most catheterization laboratories. Interventional cardiologists, therefore, rely on surrogate markers of flow. Recently, we described a computational fluid dynamics (CFD) method for predicting flow that differentiates inlet, side branch, and outlet flows during angiography. In the current study, we evaluate a new method that regionalizes flow along the length of the artery.</p><p><strong>Methods and results: </strong>Three-dimensional coronary anatomy was reconstructed from angiograms from 20 patients with chronic coronary syndrome. All flows were computed using CFD by applying the pressure gradient to the reconstructed geometry. Side branch flow was modelled as a porous wall boundary. Side branch flow magnitude was based on morphometric scaling laws with two models: a homogeneous model with flow loss along the entire arterial length; and a regionalized model with flow proportional to local taper. Flow results were validated against invasive measurements of flow by continuous infusion thermodilution (Coroventis™, Abbott). Both methods quantified flow relative to the invasive measures: homogeneous (<i>r</i> 0.47, <i>P</i> 0.006; zero bias; 95% CI -168 to +168 mL/min); regionalized method (<i>r</i> 0.43, <i>P</i> 0.013; zero bias; 95% CI -175 to +175 mL/min).</p><p><strong>Conclusion: </strong>During angiography and pressure wire assessment, coronary flow can now be regionalized and differentiated at the inlet, outlet, and side branches. The effect of epicardial disease on agreement suggests the model may be best targeted at cases with a stenosis close to side branches.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"81-89"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9552636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Determining the cause of cardiac arrest: artificial intelligence at the bedside. 确定心脏骤停的原因:床边的人工智能。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztad002
Samantha K Engrav, Jeffrey B Geske, Konstantinos C Siontis
,
{"title":"Determining the cause of cardiac arrest: artificial intelligence at the bedside.","authors":"Samantha K Engrav,&nbsp;Jeffrey B Geske,&nbsp;Konstantinos C Siontis","doi":"10.1093/ehjdh/ztad002","DOIUrl":"https://doi.org/10.1093/ehjdh/ztad002","url":null,"abstract":",","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"136-137"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/ee/ztad002.PMC10039424.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated categorization of virtual reality studies in cardiology based on the device usage: a bibliometric analysis (2010-2022). 基于设备使用的心脏病学虚拟现实研究的自动分类:文献计量学分析(2010-2022)。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztad008
Akinori Higaki, Yuta Watanabe, Yusuke Akazawa, Toru Miyoshi, Hiroshi Kawakami, Fumiyasu Seike, Haruhiko Higashi, Takayuki Nagai, Kazuhisa Nishimura, Katsuji Inoue, Shuntaro Ikeda, Osamu Yamaguchi

Aims: Currently, virtual reality (VR) constitutes a vital aspect of digital health, necessitating an overview of study trends. We classified type A studies as those in which health care providers utilized VR devices and type B studies as those in which patients employed the devices. This study aimed to analyse the characteristics of each type of studies using natural language processing (NLP) methods.

Methods and results: Literature related to VR in cardiovascular research was searched in PubMed between 2010 and 2022. The characteristics of studies were analysed based on their classification as type A or type B. Abstracts of the studies were used as corpus for text mining. A binary logistic regression model was trained to automatically categorize the abstracts into the two study types. Classification performance was evaluated by accuracy, precision, recall, F-1 score, and c-statistics of the receiver operator curve (ROC) analysis. In total, 171 articles met the inclusion criteria, where 120 (70.2%) were type A studies and 51 (29.8%) were type B studies. Type A studies had a higher proportion of case reports than type B studies (18.3% vs. 3.9%, P = 0.01). As for abstract classification, the binary logistic regression model yielded 88% accuracy and an area under the ROC of 0.98. The words 'training', '3d', and 'simulation' were the most powerful determinants of type A studies, while the words 'patients', 'anxiety', and 'rehabilitation' were more indicative for type B studies.

Conclusions: NLP methods revealed the characteristics of the two types of VR-related research in cardiology.

目前,虚拟现实(VR)构成了数字健康的一个重要方面,有必要概述研究趋势。我们将A类研究分类为医疗保健提供者使用VR设备的研究,将B类研究分类为患者使用该设备的研究。本研究旨在利用自然语言处理(NLP)方法分析每种类型研究的特点。方法与结果:检索2010 - 2022年PubMed中与VR在心血管研究中的相关文献。将研究分类为A类或b类,分析其特征。将研究摘要作为文本挖掘的语料库。一个二元逻辑回归模型被训练成自动将摘要分类为两种研究类型。通过准确度、精密度、召回率、F-1评分和ROC分析的c统计量来评价分类效果。共有171篇文章符合纳入标准,其中120篇(70.2%)为A型研究,51篇(29.8%)为B型研究。A型研究的病例报告比例高于B型研究(18.3%比3.9%,P = 0.01)。对于抽象分类,二元逻辑回归模型的准确率为88%,ROC下面积为0.98。单词“训练”、“3d”和“模拟”是A型研究中最有力的决定因素,而单词“患者”、“焦虑”和“康复”更能说明B型研究。结论:NLP方法揭示了两种类型的心脏科vr相关研究的特点。
{"title":"Automated categorization of virtual reality studies in cardiology based on the device usage: a bibliometric analysis (2010-2022).","authors":"Akinori Higaki,&nbsp;Yuta Watanabe,&nbsp;Yusuke Akazawa,&nbsp;Toru Miyoshi,&nbsp;Hiroshi Kawakami,&nbsp;Fumiyasu Seike,&nbsp;Haruhiko Higashi,&nbsp;Takayuki Nagai,&nbsp;Kazuhisa Nishimura,&nbsp;Katsuji Inoue,&nbsp;Shuntaro Ikeda,&nbsp;Osamu Yamaguchi","doi":"10.1093/ehjdh/ztad008","DOIUrl":"https://doi.org/10.1093/ehjdh/ztad008","url":null,"abstract":"<p><strong>Aims: </strong>Currently, virtual reality (VR) constitutes a vital aspect of digital health, necessitating an overview of study trends. We classified type A studies as those in which health care providers utilized VR devices and type B studies as those in which patients employed the devices. This study aimed to analyse the characteristics of each type of studies using natural language processing (NLP) methods.</p><p><strong>Methods and results: </strong>Literature related to VR in cardiovascular research was searched in PubMed between 2010 and 2022. The characteristics of studies were analysed based on their classification as type A or type B. Abstracts of the studies were used as corpus for text mining. A binary logistic regression model was trained to automatically categorize the abstracts into the two study types. Classification performance was evaluated by accuracy, precision, recall, F-1 score, and c-statistics of the receiver operator curve (ROC) analysis. In total, 171 articles met the inclusion criteria, where 120 (70.2%) were type A studies and 51 (29.8%) were type B studies. Type A studies had a higher proportion of case reports than type B studies (18.3% vs. 3.9%, <i>P</i> = 0.01). As for abstract classification, the binary logistic regression model yielded 88% accuracy and an area under the ROC of 0.98. The words 'training', '3d', and 'simulation' were the most powerful determinants of type A studies, while the words 'patients', 'anxiety', and 'rehabilitation' were more indicative for type B studies.</p><p><strong>Conclusions: </strong>NLP methods revealed the characteristics of the two types of VR-related research in cardiology.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"119-124"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/62/ztad008.PMC10039423.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9198159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Virtual healthcare solutions for cardiac rehabilitation: a literature review. 心脏康复的虚拟医疗解决方案:文献综述。
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 DOI: 10.1093/ehjdh/ztad005
Keni C S Lee, Boris Breznen, Anastasia Ukhova, Friedrich Koehler, Seth S Martin

Graphical AbstractAdherence to cardiac rehabilitation following a primary event has been demonstrated to improve quality of life, increase functional capacity, and decrease hospitalizations and mortality. Mobile technologies offer an opportunity to improve both the quality and utilization of cardiac rehabilitation, and recent clinical studies investigated this technology. This literature review summarizes the current use of mobile health, wearable activity monitors (WAMs), and other multi-component technologies deployed to support home-based virtual cardiac rehabilitation. The methodology was adapted from the Cochrane Handbook for Systematic Reviews of Interventions. We identified 2094 records, of which 113 were eligible for qualitative analysis. Different virtual cardiac rehabilitation solutions were implemented in the studies: (i) multi-component interventions in 48 studies (42.5%), (ii) WAMs in 27 studies (23.9%), (iii) web-based communications solutions, and (iv) mobile apps, both in 19 studies (16.4%). Functional capacity was the most frequently reported primary outcome (k = 37, 32.7%), followed by user adherence/compliance (k = 35, 31.0%), physical activity (k = 27, 23.9%), and quality of life (k = 14, 12.4%). Studies provided a mixed assessment of the efficacy of virtual cardiac rehabilitation in attaining either significant improvements over baseline or significant improvements in outcomes compared with conventional rehabilitation. Efficacy outcomes with virtual cardiac rehabilitation sometimes improve on the centre-based outcomes; however, superior clinical efficacy may not necessarily be the only outcome of interest. The promise of virtual cardiac rehabilitation includes the potential for increased user adherence and longer-term patient engagement. If these outcomes can be improved, that would be a significant justification for using this technology.

图表摘要:在原发性疾病后坚持心脏康复已被证明可以改善生活质量,增加功能能力,减少住院和死亡率。移动技术为提高心脏康复的质量和利用提供了机会,最近的临床研究对这项技术进行了研究。本文献综述总结了目前移动医疗、可穿戴活动监测仪(WAMs)和其他多组件技术的使用,以支持基于家庭的虚拟心脏康复。方法改编自Cochrane干预措施系统评价手册。我们确定了2094条记录,其中113条符合定性分析。研究中采用了不同的虚拟心脏康复解决方案:(i) 48项研究(42.5%)采用多组分干预,(ii) 27项研究采用WAMs (23.9%), (iii)基于网络的通信解决方案,(iv)移动应用程序,均为19项研究(16.4%)。功能能力是最常见的主要预后指标(k = 37, 32.7%),其次是使用者依从性/依从性(k = 35, 31.0%)、身体活动(k = 27, 23.9%)和生活质量(k = 14, 12.4%)。研究对虚拟心脏康复的疗效进行了混合评估,无论是在基线上取得显著改善,还是在结果上与传统康复相比取得显著改善。虚拟心脏康复的疗效结果有时优于基于中心的结果;然而,优异的临床疗效不一定是唯一的结果。虚拟心脏康复的前景包括增加用户依从性和长期患者参与的潜力。如果这些结果可以得到改善,那将是使用这项技术的一个重要理由。
{"title":"Virtual healthcare solutions for cardiac rehabilitation: a literature review.","authors":"Keni C S Lee,&nbsp;Boris Breznen,&nbsp;Anastasia Ukhova,&nbsp;Friedrich Koehler,&nbsp;Seth S Martin","doi":"10.1093/ehjdh/ztad005","DOIUrl":"https://doi.org/10.1093/ehjdh/ztad005","url":null,"abstract":"<p><p>Graphical AbstractAdherence to cardiac rehabilitation following a primary event has been demonstrated to improve quality of life, increase functional capacity, and decrease hospitalizations and mortality. Mobile technologies offer an opportunity to improve both the quality and utilization of cardiac rehabilitation, and recent clinical studies investigated this technology. This literature review summarizes the current use of mobile health, wearable activity monitors (WAMs), and other multi-component technologies deployed to support home-based virtual cardiac rehabilitation. The methodology was adapted from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. We identified 2094 records, of which 113 were eligible for qualitative analysis. Different virtual cardiac rehabilitation solutions were implemented in the studies: (i) multi-component interventions in 48 studies (42.5%), (ii) WAMs in 27 studies (23.9%), (iii) web-based communications solutions, and (iv) mobile apps, both in 19 studies (16.4%). Functional capacity was the most frequently reported primary outcome (<i>k</i> = 37, 32.7%), followed by user adherence/compliance (<i>k</i> = 35, 31.0%), physical activity (<i>k</i> = 27, 23.9%), and quality of life (<i>k</i> = 14, 12.4%). Studies provided a mixed assessment of the efficacy of virtual cardiac rehabilitation in attaining either significant improvements over baseline or significant improvements in outcomes compared with conventional rehabilitation. Efficacy outcomes with virtual cardiac rehabilitation sometimes improve on the centre-based outcomes; however, superior clinical efficacy may not necessarily be the only outcome of interest. The promise of virtual cardiac rehabilitation includes the potential for increased user adherence and longer-term patient engagement. If these outcomes can be improved, that would be a significant justification for using this technology.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"99-111"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/df/ztad005.PMC10039430.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A prospective, randomized, controlled, multicentre trial for secondary prevention in patients with chronic coronary syndrome using a smartphone application for digital therapy: the CHANGE study protocol. 使用智能手机应用进行数字治疗的慢性冠状动脉综合征患者二级预防前瞻性随机对照多中心试验:CHANGE 研究方案。
IF 3.9 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-02-15 eCollection Date: 2023-05-01 DOI: 10.1093/ehjdh/ztad012
Philip Düsing, Irina Eckardt, Stephan H Schirmer, Jan-Malte Sinning, Nikos Werner, Florian Bönner, Alexander Krogmann, Sebastian Schäfer, Alexander Sedaghat, Cornelius Müller, Georg Nickenig, Andreas Zietzer

Aims: Coronary artery disease (CAD) remains the leading cause of death worldwide. 'Stable' CAD is a chronic progressive condition, which recent European guidelines recommend referring to as 'chronic coronary syndrome' (CCS). Despite therapeutic advances, morbidity and mortality among patients with CCS remain high. Optimal secondary prevention in patients with CCS includes optimization of modifiable risk factors with behavioural changes and pharmacological therapy. The CHANGE study aims to provide evidence for optimization of secondary prevention in CCS patients by using a smartphone application (app).

Methods and results: The CHANGE study is designed as a prospective, randomized, controlled trial with a 1:1 allocation ratio, which is currently performed in nine centres in Germany in a parallel group design. 210 patients with CCS will be randomly allocated either to the control group (standard-of-care) or to the intervention group, who will be provided the VantisTherapy* app in addition to standard-of-care to incorporate secondary prevention into their daily life. The study will be performed in an open design. Outcomes will be assessed using objective data from three in-person visits (0, 12, and 24 weeks). Primary outcomes will involve adherence to secondary prevention recommendations and quality of life (QoL). The recruitment process started in July 2022.

Conclusion: The CHANGE study will investigate whether a smartphone-guided secondary prevention app, combined with a monitor function compared with standard-of-care, has beneficial effects on overall adherence to secondary prevention guidelines and QoL in patients with CCS.

Trial registration: The study is listed at the German study registry (DRKS) under the registered number DRKS00028081.

目的:冠状动脉疾病(CAD)仍然是导致全球死亡的主要原因。稳定型 "冠状动脉疾病是一种慢性进展性疾病,最近的欧洲指南建议将其称为 "慢性冠状动脉综合征"(CCS)。尽管治疗手段不断进步,但 CCS 患者的发病率和死亡率仍然居高不下。CCS患者的最佳二级预防包括通过改变行为和药物治疗来优化可改变的风险因素。CHANGE研究旨在通过使用智能手机应用程序(App)为优化CCS患者的二级预防提供证据:CHANGE 研究是一项前瞻性的随机对照试验,采用 1:1 的分配比例,目前在德国的九个中心进行,采用平行分组设计。210名CCS患者将被随机分配到对照组(标准护理)或干预组,除标准护理外,干预组还将获得VantisTherapy*应用程序,以便在日常生活中进行二级预防。研究将采用开放式设计。研究结果将通过三次面对面访问(0、12 和 24 周)的客观数据进行评估。主要结果包括对二级预防建议的依从性和生活质量(QoL)。招募过程于 2022 年 7 月开始:CHANGE研究将调查智能手机指导下的二级预防应用程序与标准护理相比,结合监测功能是否对CCS患者遵守二级预防指南的总体情况和生活质量产生有利影响:该研究已列入德国研究登记处(DRKS),登记号为 DRKS00028081。
{"title":"A prospective, randomized, controlled, multicentre trial for secondary prevention in patients with chronic coronary syndrome using a smartphone application for digital therapy: the CHANGE study protocol.","authors":"Philip Düsing, Irina Eckardt, Stephan H Schirmer, Jan-Malte Sinning, Nikos Werner, Florian Bönner, Alexander Krogmann, Sebastian Schäfer, Alexander Sedaghat, Cornelius Müller, Georg Nickenig, Andreas Zietzer","doi":"10.1093/ehjdh/ztad012","DOIUrl":"10.1093/ehjdh/ztad012","url":null,"abstract":"<p><strong>Aims: </strong>Coronary artery disease (CAD) remains the leading cause of death worldwide. 'Stable' CAD is a chronic progressive condition, which recent European guidelines recommend referring to as 'chronic coronary syndrome' (CCS). Despite therapeutic advances, morbidity and mortality among patients with CCS remain high. Optimal secondary prevention in patients with CCS includes optimization of modifiable risk factors with behavioural changes and pharmacological therapy. The CHANGE study aims to provide evidence for optimization of secondary prevention in CCS patients by using a smartphone application (app).</p><p><strong>Methods and results: </strong>The CHANGE study is designed as a prospective, randomized, controlled trial with a 1:1 allocation ratio, which is currently performed in nine centres in Germany in a parallel group design. 210 patients with CCS will be randomly allocated either to the control group (standard-of-care) or to the intervention group, who will be provided the VantisTherapy* app in addition to standard-of-care to incorporate secondary prevention into their daily life. The study will be performed in an open design. Outcomes will be assessed using objective data from three in-person visits (0, 12, and 24 weeks). Primary outcomes will involve adherence to secondary prevention recommendations and quality of life (QoL). The recruitment process started in July 2022.</p><p><strong>Conclusion: </strong>The CHANGE study will investigate whether a smartphone-guided secondary prevention app, combined with a monitor function compared with standard-of-care, has beneficial effects on overall adherence to secondary prevention guidelines and QoL in patients with CCS.</p><p><strong>Trial registration: </strong>The study is listed at the German study registry (DRKS) under the registered number DRKS00028081.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 3","pages":"207-215"},"PeriodicalIF":3.9,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/f5/ztad012.PMC10232292.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9568844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinician-to-clinician electronic consultation in cardiology is also a digital health technology for cardiovascular care. 心脏病学领域的临床医生对临床医生电子会诊也是心血管护理领域的一项数字医疗技术。
IF 3.9 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-02-09 eCollection Date: 2023-03-01 DOI: 10.1093/ehjdh/ztad011
José R González-Juanatey, Sergio Cinza Sanjurjo
{"title":"Clinician-to-clinician electronic consultation in cardiology is also a digital health technology for cardiovascular care.","authors":"José R González-Juanatey, Sergio Cinza Sanjurjo","doi":"10.1093/ehjdh/ztad011","DOIUrl":"10.1093/ehjdh/ztad011","url":null,"abstract":"","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"69-70"},"PeriodicalIF":3.9,"publicationDate":"2023-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/31/ztad011.PMC10039421.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9567932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association of electronic health literacy with behavioural and psychological coronary artery disease risk factors in patients after percutaneous coronary intervention: a 12-month follow-up study. 电子健康素养与经皮冠状动脉介入治疗后患者行为和心理冠状动脉疾病危险因素的关系:一项为期12个月的随访研究
IF 3.9 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-02-07 eCollection Date: 2023-03-01 DOI: 10.1093/ehjdh/ztad010
Gunhild Brørs, Håvard Dalen, Heather Allore, Christi Deaton, Bengt Fridlund, Cameron D Norman, Pernille Palm, Tore Wentzel-Larsen, Tone M Norekvål

Aims: Fundamental roadblocks, such as non-use and low electronic health (eHealth) literacy, prevent the implementation of eHealth resources. The aims were to study internet usage for health information and eHealth literacy in patients after percutaneous coronary intervention (PCI). Further, we aimed to evaluate temporal changes and determine whether the use of the internet to find health information and eHealth literacy were associated with coronary artery disease (CAD) risk factors at the index admission and 12-month follow-up of the same population.

Methods and results: This prospective longitudinal study recruited 2924 adult patients with internet access treated by PCI in two Nordic countries. Assessments were made at baseline and 12-month follow-up, including a de novo question Have you used the internet to find information about health?, the eHealth literacy scale, and assessment of clinical, behavioural, and psychological CAD risk factors. Regression analyses were used. Patients' use of the internet for health information and their eHealth literacy were moderate at baseline but significantly lower at 12-month follow-up. Non-users of the internet for health information were more often smokers and had a lower burden of anxiety symptoms. Lower eHealth literacy was associated with a higher burden of depression symptoms at baseline and lower physical activity and being a smoker at baseline and at 12-month follow-up.

Conclusion: Non-use of the internet and lower eHealth literacy need to be considered when implementing eHealth resources, as they are associated with behavioural and psychological CAD risk factors. eHealth should therefore be designed and implemented with high-risk CAD patients in mind.

Clinical trial registration: ClinicalTrials.gov NCT03810612 https://clinicaltrials.gov/ct2/show/NCT03810612.

目的:基本障碍,如不使用电子健康和低电子健康素养,阻碍了电子健康资源的实施。目的是研究经皮冠状动脉介入治疗(PCI)后患者健康信息和电子健康素养的互联网使用情况。此外,我们旨在评估时间变化,并确定在入院时和对同一人群进行12个月随访时,互联网查找健康信息和电子健康素养的使用是否与冠状动脉疾病(CAD)危险因素相关。方法和结果:这项前瞻性纵向研究在两个北欧国家招募了2924名接受PCI治疗的上网成人患者。在基线和12个月的随访中进行了评估,包括一个从头开始的问题:你是否使用互联网查找有关健康的信息?、电子健康素养量表,以及临床、行为和心理CAD风险因素的评估。采用回归分析。患者使用互联网获取健康信息和他们的电子健康素养在基线时是中等的,但在12个月的随访中显著降低。不使用互联网获取健康信息的人往往是吸烟者,焦虑症状负担较轻。较低的电子健康素养与基线时较高的抑郁症状负担、较低的身体活动以及基线时和12个月随访时的吸烟者相关。结论:在实施电子健康资源时,需要考虑不使用互联网和较低的电子健康素养,因为它们与行为和心理CAD风险因素有关。因此,电子健康的设计和实施应该考虑到高危CAD患者。临床试验注册:ClinicalTrials.gov NCT03810612 https://clinicaltrials.gov/ct2/show/NCT03810612。
{"title":"The association of electronic health literacy with behavioural and psychological coronary artery disease risk factors in patients after percutaneous coronary intervention: a 12-month follow-up study.","authors":"Gunhild Brørs, Håvard Dalen, Heather Allore, Christi Deaton, Bengt Fridlund, Cameron D Norman, Pernille Palm, Tore Wentzel-Larsen, Tone M Norekvål","doi":"10.1093/ehjdh/ztad010","DOIUrl":"10.1093/ehjdh/ztad010","url":null,"abstract":"<p><strong>Aims: </strong>Fundamental roadblocks, such as non-use and low electronic health (eHealth) literacy, prevent the implementation of eHealth resources. The aims were to study internet usage for health information and eHealth literacy in patients after percutaneous coronary intervention (PCI). Further, we aimed to evaluate temporal changes and determine whether the use of the internet to find health information and eHealth literacy were associated with coronary artery disease (CAD) risk factors at the index admission and 12-month follow-up of the same population.</p><p><strong>Methods and results: </strong>This prospective longitudinal study recruited 2924 adult patients with internet access treated by PCI in two Nordic countries. Assessments were made at baseline and 12-month follow-up, including a <i>de novo</i> question <i>Have you used the internet to find information about health?</i>, the eHealth literacy scale, and assessment of clinical, behavioural, and psychological CAD risk factors. Regression analyses were used. Patients' use of the internet for health information and their eHealth literacy were moderate at baseline but significantly lower at 12-month follow-up. Non-users of the internet for health information were more often smokers and had a lower burden of anxiety symptoms. Lower eHealth literacy was associated with a higher burden of depression symptoms at baseline and lower physical activity and being a smoker at baseline and at 12-month follow-up.</p><p><strong>Conclusion: </strong>Non-use of the internet and lower eHealth literacy need to be considered when implementing eHealth resources, as they are associated with behavioural and psychological CAD risk factors. eHealth should therefore be designed and implemented with high-risk CAD patients in mind.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov NCT03810612 https://clinicaltrials.gov/ct2/show/NCT03810612.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"4 2","pages":"125-135"},"PeriodicalIF":3.9,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a8/75/ztad010.PMC10039428.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9552635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European heart journal. Digital health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1